Press Release - With only 32% of Indian companies offering paternity leave, Prega News's Father's Day campaign calls for a shift in how the country sees new fathers
With only 32% of Indian companies offering paternity leave, Prega News's Father's Day campaign calls for a shift in how the country sees new fathers
National, 17th June 2026: Prega News, India's No. 1 pregnancy care brand with an 86% market share (MAT Q4 FY2026, IQVIA), has launched a campaign this Father's Day that turns the spotlight on paternity leave and on the quiet but critical role fathers play in the earliest days of parenthood.
The campaign goes live with a film that captures a reality many Indian families know well: a new father who wants to stay, who is needed at home, but who has little systemic support to do so. According to available data, only 32% of Indian companies currently offer paternity leave, discouraged in practice or treated as optional rather than a right.
The challenge is compounded by how Indian family structures have evolved. With more households becoming nuclear and both partners working, new parents can no longer rely on the extended family support that once helped absorb the demands of early parenthood. In this reality, a father's presence at home is not just emotionally meaningful — it is practically essential.
The campaign makes the case that a father's role in those early days is not supplementary. It is foundational. A new mother recovering from childbirth needs a partner, not just well-wishers. A newborn benefits from the presence of both parents. And a father who is there from the beginning is not doing anyone a favour — he is doing his part.
The film and the broader campaign are built around four ideas: the emotional bond that forms between a father and a newborn in those first days, the practical and emotional support a father provides to a recovering partner, the growing reality of shared parenting in Indian households and the cultural shift that is slowly but meaningfully changing how involved fatherhood is perceived in the country.
Prega News is holding up a mirror to a gap that exists and asking, gently but clearly, for a better deal for new fathers. Working with SG Media, the brand has brought this intent to life through a campaign film that centres the everyday reality of a new father caught between the demands of work and the pull of home.
"Prega News has always believed that parenthood is a shared journey. Our campaigns have spoken to mothers, but we have always known that behind every new mother is a partner who is equally overwhelmed, equally in love and equally in need of the time and space to be present. This Father's Day, we want to celebrate the fathers who show up fully and start a conversation about making it easier for every father to do the same. Paternity leave is not a perk. It is part of how we build stronger families,"said Joy Chatterjee, Vice President and Head of Sales and Marketing, Mankind Consumer Products Private Limited.
The campaign film is live across social media platforms
Data sources
86% market share: IQVIA, MAT Q4 FY2026
About Mankind Pharma
About Mankind Pharma Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynaecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of BSV, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind's distribution network includes a robust field force of 18,500+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 32 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 7 dedicated R&D facilities backed by more than 750 scientists.
For more information, visit www.mankindpharma.com or contact:
Natasha Raj - 9205057627 - natasha.raj@mankindpharma.com
Apoorva Sharma - 9999739452 - apoorva.sharma@adfactorspr.com
Comments
Post a Comment